HOTCHKIS & WILEY's ELV Position Overview
HOTCHKIS & WILEY (via Hotchkis & Wiley Capital Management LLC) currently holds 2.0M shares of Elevance Health, Inc. (ELV) worth $660.94 M, representing 2.04% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, HOTCHKIS & WILEY has maintained a long-term strategic position in ELV, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2016, adding 1.2M shares. Largest reduction occurred in Q2 2017, reducing 1.2M shares.
Analysis based on 13F filings available since 2013 Q2
HOTCHKIS & WILEY's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by HOTCHKIS & WILEY
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2014 | +2.71 M | New Buy | 2.71 M | $125.67 |
| Q1 2015 | -418,979 | Reduce 15.48% | 2.29 M | $154.41 |
| Q2 2015 | -831,182 | Reduce 36.34% | 1.46 M | $164.14 |
| Q3 2015 | +869,193 | Add 59.69% | 2.33 M | $140.00 |
| Q4 2015 | +58,018 | Add 2.50% | 2.38 M | $139.44 |
| Q1 2016 | -94,128 | Reduce 3.95% | 2.29 M | $138.99 |
| Q2 2016 | +176,293 | Add 7.70% | 2.47 M | $131.34 |
| Q3 2016 | +1.24 M | Add 50.36% | 3.71 M | $125.31 |
| Q4 2016 | -71,746 | Reduce 1.94% | 3.64 M | $143.77 |
| Q1 2017 | -85,597 | Reduce 2.35% | 3.55 M | $165.38 |
| Q2 2017 | -1.17 M | Reduce 32.93% | 2.38 M | $188.13 |
| Q3 2017 | +12,975 | Add 0.54% | 2.39 M | $189.88 |
| Q4 2017 | -927,092 | Reduce 38.73% | 1.47 M | $225.01 |
| Q1 2018 | -134,917 | Reduce 9.20% | 1.33 M | $219.70 |
| Q2 2018 | -26,925 | Reduce 2.02% | 1.3 M | $238.03 |
| Q3 2018 | -108,584 | Reduce 8.32% | 1.2 M | $274.05 |
| Q4 2018 | -612,522 | Reduce 51.20% | 583,770 | $262.63 |
| Q1 2019 | -18,469 | Reduce 3.16% | 565,301 | $286.98 |
| Q2 2019 | +292,610 | Add 51.76% | 857,911 | $282.21 |
| Q3 2019 | +309,390 | Add 36.06% | 1.17 M | $240.10 |
| Q4 2019 | +96,973 | Add 8.31% | 1.26 M | $302.03 |
| Q1 2020 | +396,620 | Add 31.37% | 1.66 M | $227.04 |
| Q2 2020 | +5,890 | Add 0.35% | 1.67 M | $262.98 |
| Q3 2020 | +388,905 | Add 23.33% | 2.06 M | $268.59 |
| Q4 2020 | +252,647 | Add 12.29% | 2.31 M | $321.09 |
| Q1 2021 | +300,302 | Add 13.01% | 2.61 M | $358.95 |
| Q2 2021 | -156,294 | Reduce 5.99% | 2.45 M | $381.80 |
| Q3 2021 | -68,916 | Reduce 2.81% | 2.38 M | $372.80 |
| Q4 2021 | -286,740 | Reduce 12.03% | 2.1 M | $463.54 |
| Q1 2022 | -376,181 | Reduce 17.94% | 1.72 M | $491.22 |
| Q2 2022 | -478,177 | Reduce 27.79% | 1.24 M | $482.58 |
| Q3 2022 | -164,088 | Reduce 13.21% | 1.08 M | $454.24 |
| Q4 2022 | -279,687 | Reduce 25.94% | 798,555 | $512.97 |
| Q1 2023 | +492,237 | Add 61.64% | 1.29 M | $459.81 |
| Q2 2023 | +298,562 | Add 23.13% | 1.59 M | $444.29 |
| Q3 2023 | +133,453 | Add 8.40% | 1.72 M | $435.42 |
| Q4 2023 | -108,477 | Reduce 6.30% | 1.61 M | $471.56 |
| Q1 2024 | -113,791 | Reduce 7.05% | 1.5 M | $518.54 |
| Q2 2024 | -186,960 | Reduce 12.46% | 1.31 M | $541.86 |
| Q3 2024 | -70,578 | Reduce 5.37% | 1.24 M | $520.00 |
| Q4 2024 | +532,611 | Add 42.85% | 1.78 M | $368.90 |
| Q1 2025 | +1,972 | Add 0.11% | 1.78 M | $434.96 |
| Q2 2025 | -359,142 | Reduce 20.20% | 1.42 M | $388.96 |
| Q3 2025 | +627,038 | Add 44.21% | 2.05 M | $323.12 |
HOTCHKIS & WILEY's Elevance Health Investment FAQs
HOTCHKIS & WILEY first purchased Elevance Health, Inc. (ELV) in Q4 2014, acquiring 2,706,336 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY has held Elevance Health, Inc. (ELV) for 44 quarters since Q4 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY's largest addition to Elevance Health, Inc. (ELV) was in Q4 2014, adding 2,706,336 shares worth $340.1 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, HOTCHKIS & WILEY's firm, Hotchkis & Wiley Capital Management LLC, owns 2,045,480 shares of Elevance Health, Inc. (ELV), valued at approximately $660.94 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Elevance Health, Inc. (ELV) represents approximately 2.04% of HOTCHKIS & WILEY's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY's peak holding in Elevance Health, Inc. (ELV) was 3,707,313 shares, as reported at the end of Q3 2016. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.